Biopharmaceutical manufacturers make significant investments when developing new therapies, each with the promise of improving lives while generating a financial return. But clinical data alone won’t...
High medication adherence rates are frequently achieved in clinical trials. But when a drug therapy receives regulatory approval and is launched in the real world, successful adherence becomes more...
While the full impact of COVID-19 on our industry continues to unfold, several trends have begun to emerge. Clear shifts in consumer behavior, communication channels, and healthcare access have...
